AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s.